Pridopidine improves overall mitochondrial function in cellular models of Huntington's disease

被引：0
|
作者：
Naia, L. [1 ]
Maranga, C. [1 ]
Lopes, C. [1 ]
Geva, M. [2 ,3 ]
Hayden, M. [3 ]
Cristina Rego, A. [1 ,4 ]
机构：
[1] Ctr Neurosci & Cell Biol, Coimbra, Portugal
[2] Teva Pharmaceut Ind, Petah Tiqwa, Israel
[3] Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC, Canada
[4] Univ Coimbra, Fac Med, Coimbra, Portugal
来源：
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION | 2018年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
W2-O10
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [41] Mitochondrial function and huntingtin proteostasis predict striatal vulnerability in Huntington's Disease
    Soares, Tania R.
    Pinho, Brigida R.
    Duchen, Michael R.
    Oliveira, Jorge M. A.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2019, 49 : 60 - 60
  • [42] AN UPDATE ON THE PROOF-HD PHASE 3 TRIAL: PRIDOPIDINE'S OUTCOME ON FUNCTION IN HUNTINGTON
    Reilmann, Ralf
    Feigin, Andrew
    Rosser, Anne
    Kostyk, Sandra
    Geva, Michal
    Gershoni-Emek, Noga
    Boot, Diderik
    Cohen, Yael
    Goldberg, Y. Paul
    Hayden, Michael R.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 : A97 - A97
  • [43] Pridopidine for the Improvement of Motor Function in Patients With Huntington's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Chen, Shujun
    Liang, Tianyu
    Xue, Tao
    Xue, Shouru
    Xue, Qun
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [44] Efficacy and safety of the dopaminergic stabilizer pridopidine (ACR16) in patients with Huntington's disease
    Lundin, A.
    Dietrichs, E.
    Haghighi, S.
    Goeller, M.-L.
    Heiberg, A.
    Loutfi, G.
    Widner, H.
    Wiktorin, K.
    Wiklund, L.
    Svenningsson, A.
    Sonesson, C.
    Waters, N.
    Waters, S.
    Tedroff, J.
    MOVEMENT DISORDERS, 2010, 25 (07) : S274 - S274
  • [45] Metoprolol-pridopidine drug-drug interaction and food effect assessments of pridopidine, a new drug for treatment of Huntington's disease
    Rabinovich-Guilatt, Laura
    Steiner, Lilach
    Hallak, Hussein
    Pastino, Gina
    Muglia, Pierandrea
    Spiegelstein, Ofer
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (10) : 2214 - 2224
  • [46] The effect of mild and moderate renal impairment on the pharmacokinetics of pridopidine, a new drug for Huntington's disease
    Rabinovich-Guilatt, L.
    Siegler, K. E.
    Schultz, A.
    Halabi, A.
    Rembratt, A.
    Spiegelstein, O.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 81 (02) : 246 - 255
  • [47] C/EBPβ Regulates TFAM Expression, Mitochondrial Function and Autophagy in Cellular Models of Parkinson's Disease
    Sierra-Magro, Ana
    Bartolome, Fernando
    Lozano-Munoz, David
    Alarcon-Gil, Jesus
    Gine, Elena
    Sanz-SanCristobal, Marina
    Alonso-Gil, Sandra
    Cortes-Canteli, Marta
    Carro, Eva
    Perez-Castillo, Ana
    Morales-Garcia, Jose A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (02)
  • [48] Efficacy and Safety of the Dopaminergic Stabilizer Pridopidine (ACR16) in Patients With Huntington's Disease
    Lundin, Anders
    Dietrichs, Espen
    Haghighi, Sara
    Goller, Marine-Louise
    Heiberg, Arvid
    Loutfi, Ghada
    Widner, Hakan
    Wiktorin, Klas
    Wiklund, Leif
    Svenningsson, Anders
    Sonesson, Clas
    Waters, Nicholas
    Waters, Susanna
    Tedroff, Joakim
    CLINICAL NEUROPHARMACOLOGY, 2010, 33 (05) : 260 - 264
  • [49] Mitochondrial abnormalities in neurodegenerative models and possible interventions: Focus on Alzheimer's disease, Parkinson's disease, Huntington's disease
    Pantiya, Patcharapong
    Thonusin, Chanisa
    Chattipakorn, Nipon
    Chattipakorn, Siriporn C.
    MITOCHONDRION, 2020, 55 : 14 - 47
  • [50] Selenomethionine Improves Mitochondrial Function by Upregulating Mitochondrial Selenoprotein in a Model of Alzheimer's Disease
    Chen, Chen
    Chen, Yao
    Zhang, Zhong-Hao
    Jia, Shi-Zheng
    Chen, Yu-Bin
    Huang, Shao-Ling
    Xu, Xin-Wen
    Song, Guo-Li
    FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
12345